Hanhai Gene is committed to significantly reducing the cost of genetic testing and providing high-quality genetic testing services. At present, the third-generation single-molecule direct sequencing technology has been successfully developed. This technology can greatly simplify the gene detection process, reduce sequencing costs and detection cycles by directly reading DNA and RNA information in blood or tissue.

Guangdong Wuzhou Pharmaceutical Co., Ltd. is a high-tech enterprise in Guangdong Province, a private technology enterprise in Guangdong Province, a national drug GMP certified enterprise, and an ISO9001:2000 quality management system certified enterprise; The company's "Tianqiao Brand" trademark is a well-known trademark in Guangdong Province;

Jiangxi Longlai Biopharmaceutical Co., Ltd. was founded in 2009 by Dr. Wu Shengwen, a renowned overseas expert who returned to China. It was completed in 2011 and merged with the American company Kairuist (Suzhou) Biochemical Co., Ltd. at the end of 2012. Currently, Dr. Wu Shengwen serves as the President of the merged new company and also serves as the Chairman and General Manager of Longlai Company. The company is led by internationally renowned investment bank Kaipeng Huaying from the United States, with other investors including Israel, Hong Kong, Japan, Suzhou, and Jiangxi Venture Capital. The company invested 100 million yuan in personnel in the early stage

Zhongke Hongji Biotechnology Co., Ltd. was established on April 14, 2010, with a registered capital of RMB 500 million. Its business scope is the research, development, and sales of biotechnology products. The company's construction adheres to the requirements of industrialization, agglomeration, and international development, adhering to the combination of expanding industrial scale and enhancing independent innovation capabilities, in order to accelerate the development of industries such as biopharmaceuticals, bio based chemicals, biomaterials, biological manufacturing, and biological environmental protection.

Boji Medical Technology Co., Ltd(known as Boji biomedicals with the stock code of 300404) was founded in 2002 and listed on Shenzhen GEM in 2015. Boji is a new high-tech enterprise(CRO+CDMO) that provides one-stop service for domestic and abroad pharmaceutical enterprises, such as the R&D of drugs, medical devices and health products. Headquartered in the wisdom city of Tianhe District in Guangzhou, the company has gathered nearly 100 biomedical R&D talents and registered legislative experts with an area of nearly 3000 square meters. The company owns 9 wholly-owned subsidiaries with different business and more than 10 holding and shareholding companies.

The headquarters of Canadian HONSON Pharmaceutical Co., Ltd. is located in Toronto. It is a natural pharmaceutical group enterprise that integrates raw material supply, research and development, and production. It is also one of the first manufacturers to receive GMP recognition from the Canadian Ministry of Health, with multiple doctoral and master's experts in pharmacy, nutrition, and natural medicine. Has Health Canada NHPD certification and over 50 Health Canada licensed formulas.